APP下载

老年痴呆的发病机制及临床药物治疗分析

2016-02-05吴冬梅

中国卫生标准管理 2016年8期

高 阳 李 轩 尹 磊 郑 凌 吴冬梅



老年痴呆的发病机制及临床药物治疗分析

高 阳 李 轩 尹 磊 郑 凌 吴冬梅

【摘要】目的 探讨老年痴呆的发病机制,分析临床药物治理效果。方法 选择医院2014年4月~2015年8月收治的老年痴呆患者86例,随机分为A组与B组,每组43例,A组患者给予奥氮平治疗,B组患者给予奋乃静治疗,均治疗4周,观察两组患者的临床治疗效果,对比两组患者治疗前后的生活质量、智能状态及日常生活能力。结果 治疗前,两组患者生活质量、智能状态及日常生活能力评分差异无统计学意义(P>0.05);经过治疗后,A组患者治疗效果、生活质量、智能状态及日常生活能力评分高于B组,差异具有统计学意义(P<0.05)。结论 临床治疗老年痴呆患者时,奥氮平治疗效果优于奋乃静,可有效的提高患者的生活质量。

【关键词】老年痴呆;发病机制;药物治疗

Objective To study the pathogenesis of alzheimer disease,and analyze clinical drug treatment effect. Methods To select 86 patients of alzheimer disease from April 2014 to August 2015 and divided them into Group A and Group B averagely. Group A were given olanzapine treatment,B group were given perphenazine therapy,both of their times were 4 weeks,their clinical treatment effects were observed,and their life quality,intelligence status and daily life ability score were compared. Results Before treatment,both of their life quality,intelligence status and daily life ability score had no statistically significant difference(P>0.05). After treatment,the patients of group A's therapeutic effect,life quality,intelligent and daily life ability score were higher than group B,there were statistically significant difference(P<0.05). Conclusion For the clinical treatment of alzheimer's disease,olanzapine treatment is better than that of perphenazine,and can effectively improve the patient's quality of life.

【Key words】 Alzheimer disease,Pathogenesis,Drug treatment

老年痴呆为临床常见病,症状主要表现为认知障碍、记忆障碍,降低患者的日常生活能力及自理能力,影响患者的生活质量。临床治疗老年痴呆患者时,多采用药物治疗,具有良好的治疗效果,本院以收治的老年痴呆患者为研究对象,探讨其发病机制,并给予药物治疗,取得良好的治疗效果[1-3],现将治疗结果报告如下。

1 资料与方法

1.1一般资料

选择医院2014年4月~2015年8月收治的老年痴呆患者86例,男50例,女46例;年龄51~84岁,平均(62.3±3.4)岁;病程6个月~5年,平均(1.6±2.1)年;痴呆病类型:血管性痴呆21例,脑创伤痴呆16例,路易体痴呆13例,额颞叶痴呆10例,帕金森病痴呆10例,阿尔茨海默症16例。……

登录APP查看全文